The Simplexa™ HSV 1 & 2 Direct assay system is a real-time PCR that enables the direct amplification, detection and differentiation of HSV-1 and/or HSV-2 DNA from unprocessed CSF specimens without nucleic acid extraction.
Reported
1-2 days
Synonyms
HSV by PCR
HSVCSF PCR
HSV 1 & 2 Subtype, CSF
Department
Immunology
Reference Interval
Herpes simplex virus (HSV) 1/2 DNA not detected by real-time PCR Critical value: Positive
Interpretive Data
The Diasorin Molecular Simplexa® HSV 1 & 2 Direct is intended for use on the LIAISON®
MDX instrument for the qualitative detection and differentiation of HSV-1 and HSV-2 DNA
in cerebrospinal fluid (CSF) samples from patients suspected of herpes simplex virus (HSV)
infections of the central nervous system (CNS). This test is intended as an aid in the diagnosis of HSV-1 and HSV-2 infections of the CNS.
Negative results do not preclude HSV-1 or HSV-2 infection and should not be used as the sole
basis for treatment or other patient management decisions.
The assay is not intended for use as a donor screening test. The assay is for professional use
The Simplexa™ HSV 1 & 2 Direct assay system is a real-time PCR that enables the direct amplification, detection and differentiation of HSV-1 and/or HSV-2 DNA from unprocessed CSF specimens without nucleic acid extraction.
Reported
1-2 days
Synonyms
HSV by PCR
HSVCSF PCR
HSV 1 & 2 Subtype, CSF
Department
Immunology
Result Interpretation
Reference Interval
Herpes simplex virus (HSV) 1/2 DNA not detected by real-time PCR Critical value: Positive
Interpretive Data
The Diasorin Molecular Simplexa® HSV 1 & 2 Direct is intended for use on the LIAISON®
MDX instrument for the qualitative detection and differentiation of HSV-1 and HSV-2 DNA
in cerebrospinal fluid (CSF) samples from patients suspected of herpes simplex virus (HSV)
infections of the central nervous system (CNS). This test is intended as an aid in the diagnosis of HSV-1 and HSV-2 infections of the CNS.
Negative results do not preclude HSV-1 or HSV-2 infection and should not be used as the sole
basis for treatment or other patient management decisions.
The assay is not intended for use as a donor screening test. The assay is for professional use
